0001772745-19-000001.txt : 20190411 0001772745-19-000001.hdr.sgml : 20190411 20190411095424 ACCESSION NUMBER: 0001772745-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190411 DATE AS OF CHANGE: 20190411 EFFECTIVENESS DATE: 20190411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nimble Therapeutics, Inc. CENTRAL INDEX KEY: 0001772745 IRS NUMBER: 833869024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-337001 FILM NUMBER: 19743001 BUSINESS ADDRESS: STREET 1: 1741 BLACK CHERRY CT. CITY: VERONA STATE: WI ZIP: 53593 BUSINESS PHONE: 608-338-2340 MAIL ADDRESS: STREET 1: 1741 BLACK CHERRY CT. CITY: VERONA STATE: WI ZIP: 53593 D 1 primary_doc.xml X0708 D LIVE 0001772745 Nimble Therapeutics, Inc. 500 South Rosa Road Madison WI WISCONSIN 53719 608-257-3501 DELAWARE None None Corporation true 2019 Jigar Patel 500 South Rosa Road Madison WI WISCONSIN 53719 Executive Officer Director Rob Hart 360 Post Street Suite 601 San Francisco CA CALIFORNIA 94108 Director Deval Lashkari 360 Post Street Suite 601 San Francisco CA CALIFORNIA 94108 Director Biotechnology Decline to Disclose 06b false 2019-04-02 false true false 0 10000000 10000000 0 false 3 0 0 0 true Proceeds will be used for working capital and other general corporate purposes. The executive officers will receive standard compensation from the Issuer's revenues and investment proceeds. false Nimble Therapeutics, Inc. Jigar Patel Jigar Patel Chief Executive Officer 2019-04-11